GLP-1 discovery may offer even better appetite suppression than Ozempic
Ozempic maker Novo Nordisk says it has developed a compound that’s shown to be a one-two punch for appetite suppression and weight loss in mice. Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel full for longer. This new potential therapy harnesses the power of GLP-1 … Read more